text:
Configurations & Customizations
APIs, SSO, Data Delivery & Integrations
Consultation - Advisory Services for in-house Systems
ELM / Practice Management / Litigation
Enterprise Case Manager
Case Data Automation
Causelists & Positions
Workflows and Analytics
MIS, Reporting, Data Management
Dashboards, Analytics, Actionable Statistics
Alerts - Cases, Dates, Orders, Board, Judgements & more!
Pre-Litigation Solution
Notice Management
Notice Generation & Templates
Manage Lawyers
Manage Billing & Budgets / Spend Management
Manage Scheduling with Auto Court Data Integration
Practice Management / Matter Management - Custom Workflows
Research & Legal Tools
Case Law / Judgements Database
Live, Human Assistance
AI Powered Suggestions / Summaries
100+ All India Manuals' Comparitive Ciataions
Write Articles - Get Published
Ready, Topic-wise Case Law Diaries
Delivery of judgements - alerts on documents
Acts / Laws / Statutes / Amendments / Forms
Calculators - Court Fee, Property Conversion, and many more
Police Stations (w Jurisdiction), Advocates, and more directories
Intellectual Property [ markMyIP ]
Causelists - CyAT, IPAB, Daily / Monthly
Patents Manage & Search ALL
Copyrights Manage & Search ALL
TradeMarks Manage & Search ALL
AUTO SOURCED - TM / © / Patents
Auto Aggregation of Related Dates, Documents & Much More
Public Search of Marks
TM Likely Infringement Alerts
TM Pre Filing Similarity Search
Analytics, alerts, reminders & more
Compliance [ CompliSync ]
Monitor & Centralize Compliance
Assign, search, filter, sort & more
Time based / Event based / ect - Configure
Alerts on related GRs, Notifications, Circulars, Gazettes, etc
Professional Assistance & Interaction
Updates on law changes and impact
Analytics, Escalation, Highlight Risks
Multiple Roles / Levels for Access
Contracts [ ContractEXE ]
Maintain and Manage Lifecycle
Workflow, Renewals, Action Items, Alerts, etc
Text, Data & Intelligence Extraction
PCTMS - Post Contract Tracking Management System **
Clause Library AND Ready Formats
Collaborative Tools Available
Central Repository of all documents
Auto summary and keywording for contracts
Digital Signature Integration
LegaTrace - Tracing Legal Info Across India
Litigation Reports - Detailed
Trace Litigation, MCA, ROC, Info
Defaulter Lists - Across the country
GST, PAN, IP Ownership, Social Media, and much more
FIR Search*
Find Lawyers
Find Execution Partners
Litigation Management*
Arbitration & Mediation
LawyerServices Members' Log In
Enter OTP Sent To Your E-Mail:
Forgot Password?
w w w .
a w y e r
e r v i c e s . i n
Sun Pharma Laboratories Limited
BDR Pharmaceuticals International Pvt. Ltd. & Another
CS(COMM.). No. 757 of 2017
Decided On,
05 June 2020
High Court of Delhi
By, THE HONOURABLE MR. JUSTICE JAYANT NATH
For the Plaintiff: Hemant Singh, Mamta Jha, Wasee Shuaib Ahmed, Advocates. For the Defendants: D1, A.J. Tahir, Advocate, D2, Dayan Krishnan, Sr. Advocate, Rishi Agarwala, Niyati Kohlim, Pranjit Bhattacharya, Megha Bengani, Akashi Lodha, Sanjeevi Sheshadri, Advocates.
Judgment Text
1. This suit is filed by the plaintiff seeking a decree of permanent injunction to restrain the defendants etc. from manufacturing, marketing, selling, offering for sale, advertising, directly or indirectly dealing in medicinal preparations under the impugned mark LULIBET or any other mark that may be visually, structurally or phonetically deceptively similar to the plaintiff's trademark LABEBET amounting to infringement of registered trademark of the plaintiff. Other connected reliefs are also sought.
2. The above matter came up for hearing on 4.1.2018 when the court passed the following order:-
"Written statement of the defendant no.1 is taken on record.
The suit is listed for framing of issues if any and for hearing of the application for interim relief.
The counsel for the plaintiff and the senior counsel for the defendant no. 2 have been heard.
The counsel for defendant No.1 adopts the arguments of the senior counsel for defendant No.2. The plaintiff has sued inter alia for permanent injunction restraining infringement of trade mark and passing off in relation to its medicinal preparation 'LABEBET' by the defendants by adoption of the mark 'LULIBET', also for medicinal preparation.
There is no interim injunction till now.
The counsel for the plaintiff on enquiry states that while the medicine of the plaintiff is for the ailment of hypertension and is marketed in tablet and injection form, the medicine of the defendants is for the ailment of fungal infection and marketed in ointment and spray form.
The senior counsel for the defendant No.2 on enquiry, states that the defendant No.2 is manufacturing the medicine 'LULIBET' and the defendant No.1 is marketing the same.
I have enquired from the counsel for the plaintiff whether not in the aforesaid circumstances, there is no possibility of confusion and deception since the two medicines are for different ailments and since, to my knowledge, there is no medicine available in the form of ointment or spray for the ailment of hypertension.
The counsel for the plaintiff has argued (i) that the registration of the mark of the plaintiff is in Class-V and relating to pharmaceutical and medicinal preparations in general and not for the pharmaceutical preparation for the ailment of hypertension only; (ii) that thus Section 29(i) will apply; (iii) that the possibility of patients with the ailment of fungal infection consuming the tablet or being treated with an injection of the product of the plaintiff exists inasmuch as for such ailments medicines in tablet and injection form are also available; and (iv) reliance is placed on Cadila Health Care Ltd. Vs. Cadila Pharmaceuticals Ltd., AIR 2001 SC 1952.
Per contra, the senior counsel for the defendants No.2 has (i) drawn attention to page 42 of the plaintiff's documents to show that the molecule of the medicine of the plaintiff 'Labetalol Hydrochloride IP 100 mg' and to page 6 of the defendants' documents to show that the molecule of the medicine of the defendants is 'Luliconazole'; (ii) has drawn attention to page 52 of the Part-I file to show that for fungal infection, large number of other medicines with the molecule name 'Luliconazole' are available; (iii) has relied on M/s. Panacea Biotee Ltd. Vs. M/s. Recon Ltd., AIR 1997 Delhi 244; and, (iv) has contended that the plaintiff in the plaint has admitted that the defendants also have applied for registration and has not opposed the application and is thus not entitled to injunction.
On enquiry, the counsel for the plaintiff states that the Registrar of Trade Marks does not have power to entertain an objection after the time prescribed for filing objection of four months from the date of advertisement and the only remedy of a person who has so missed the opportunity is to apply the cancellation of the registration if any granted.
I have during the hearing informed the counsels that considering the nature of the controversy, the suit, insofar as for the relief of permanent injunction, will be disposed of on the basis of hearing today and considering the facts aforesaid and the fact that the defendants are marketing only since July 2016, no case of the plaintiff being entitled to any damages or other reliefs is made out.
The senior counsel for the defendant No.2 states that in that eventuality, the hearing be deferred.
List on 22nd February, 2018."
3. On 22.2.2018 the court further passed the following order:-
"This order is in continuation of the earlier order dated 4th January 2018.
The counsel for the plaintiff states that the plaintiff is agreeable to the proposal mooted in the order dated 4th January 2018.
The Senior counsel for the defendant no. 1 also on instructions states that the defendant no. 1 is not agreeable to the proposal.
The counsel for the plaintiff on request was permitted to contend further and during the course of hearing it has been enquired from him, whether he has any objection to use by the defendants of the word/expression 'LULI' which is derived from the molecule of the medicine of the defendants.
The counsel for the plaintiff states that the plaintiff has no objection and the objection is only on account of the overall similarity.
The counsel for the plaintiff has also referred to the dicta of this Court in Himalaya Drug Company vs. S.B.L.Limited, 2013 (53) PTC 1 Del (DB) where injunction against use of 'LIV-T', a homeopathic drug was granted on account of being in infringement of 'Liv.52", an Ayurvedic drug and the argument that the registered proprietor cannot have any right in the word 'LIV' was rejected by holding that the word 'LIV', represented in a particular form could not be excluded for the purposes of measuring deceptive resemblance.
The counsel for the plaintiff has further contended that the registered proprietor has a right to use the mark for the goods of the description for which it is registered and even if the mark for the time being is used only for one of the products of such description. It is contended that the registered mark 'LABEBET' of the plaintiff is with respect to medicinal and pharmaceutical preparations and the plaintiff will have a right to sue for infringement as long as similar/deceptive mark is used for any medicinal/pharmaceutical preparation. Reliance in this regard in addition to Himalaya Drug Company supra is also placed on Novartis AG vs. Crest Pharma Pvt. LTD. 2009 (41) PTC 57 Del where interim injunction with respect to the antibiotic in the form of injection in the mark 'CECEF' was granted for the reason of amounting to passing off of the plaintiff's mark 'SECEF' in the form of tablet or oral suspension and for UTI infections.
I have enquired to the senior counsel for the defendant No.2 whether the defendant No.2 is agreeable to, while retaining the part 'LULI' of its mark, altering the part 'BET' of its mark.
It is deemed appropriate to defer further hearing if any required to enable the defendants to take instructions.
List on 6th March 2018."
4. In response to the above orders learned senior counsel for defendant No.2 on 22.3.2018 submitted that defendant No.2 would like to contest the suit on merits. Learned senior counsel for defendants No.1 and 2 also stated that defendants will not manufacture or market any product in tablet or injectable form under the mark 'LULIBET'.
5. I have heard learned counsel for the plaintiff Mr. Hemant Singh and learned counsel for defendant No.1 and learned senior counsel for defendant No.2 Mr. Dayan Krishnan. On the relief of decree of permanent injunction as sought by the plaintiff in terms of the above noted orders the suit can be disposed of, at this stage, itself. Further, as noted in the above orders the defendants are marketing only since July 2016. Hence, no case of the plaintiff being entitled to any damages or other relief is made out as noted in the order dated 4.1.2018 read with order dated 22.02.2018.
6. The case of the plaintiff as stated in the plaint is that it is carrying on business of manufacturing and marketing pharmaceuticals and medicinal preparations for past several decades. One of the medicines manufactured by the plaintiff is under the mark LABEBET which was coined in 2009. The product is used for treatment of hypertension. The said product of the plaintiff LABEBET contains salt/molecule LABETALOL, an antihypertensive drug and sold in tablets as well as injection forms. The said drug is said to have side effects and can cause headache, tiredness, dizziness etc. It is the case of the plaintiff that the said trademark LABEBET has been used extensively and commercially by the plaintiff. The trademark has acquired immense goodwill and reputation as a badge of quality drugs.
7. It is also pleaded that the plaintiff is the registered proprietor of the said trademark LABEBET in class 5 which was registered on 30.10.2009. Hence, it is pleaded that being a registered proprietor the plaintiff has statutory rights thereof in India and use of an identical or deceptively similar trademark by any unauthorised person, it is pleaded, would constitute infringement of the plaintiff's well-known trademark under section 29 of the Trade Marks Act, 1999 (hereinafter referred to as "the Act") and the same would also be in violation of the plaintiff's statutory right of exclusive use under section 28 of the Act. The sales figures of the said drug LABEBET are given in the plaint and in 2016 - 2017 a sale of Rs.1347 lacs was made. It is pleaded that the mark LABEBET has become a well-known mark as per provisions of section 2(1)(zg) of the Act.
8. Regarding the defendant No.1 it is pleaded that in first week of October 2017 the plaintiff through its field force came across defendants' product, an antifungal cream, under the impugned trademark LULIBET. It is claimed that the said mark when compared as a whole, is deceptively similar to that of the plaintiff inasmuch as the impugned mark is phonetically and structurally similar to the plaintiff's trademark LABEBET. Further, the said product is sold in the common medicine shops in Delhi. It is pleaded that applying the test of imperfect recollection when compared as a whole there is every likelihood of one being confused with the other. It is further pleaded that the medicine under the impugned mark LULIBET contains salt/molecule Luliconazole, which is used for treatment of fungal infections whereas the plaintiff's product under the mark LABEBET is used for treatment of hypertension. Mixing up of the competing products on account of close phonetic and structural similarity would lead to disastrous consequences and hence the act of the defendant is liable to be injuncted.
9. It is further pleaded that the plaintiff thereafter conducted a search of the defendant's impugned trademark with the Trademark Registry and found that an application for the trademark LULIBET dated 30.05.2016 and 16.06.2016 in class 5 had been filed by defendant No.2. Plaintiff could not oppose the application since the publication of the said mark in the Trade Mark Journal inadvertently escaped the attention of the plaintiff. The objections could not be filed now, at this stage.
10. It is further pleaded that the conduct of the defendant is unethical, unfair, lacks bona fide and is unlawful. Considering that the goods in question are medicinal preparations sold through same trade channels under a deceptively similar trademark, the defendants are creating confusion and deception amongst stockiest, dealers, chemists, consumers and physicians. It is pleaded that the act of the defendant constitutes infringement of trademark, passing off and unfair competition.
11. Defendant No.2 has filed his written statement. It is pleaded that the product LULIBET cream contained in lamitube was launched by defendant No. 2 in 2016. The said product of the defendant is unique within the Luliconazole range of creams as the same is being manufactured with 'Enhanced Emollient Penetration Technology'. Further, the defendant's product has other unique ingredients. These value added ingredients and other special features of the defendant's product offer superior results than similar products. It is pleaded that owing to its special characteristic features, superior efficacy, the defendant's product LULIBET is at the centre stage evincing high interest and popularity. The sales figures it is pleaded demonstrates the phenomenal success, popularity and standing of the product. It is stated in the year 2016-17 sales figure of 10.90 crores was registered.
12. It is pleaded that the trade names LABEBET of the plaintiff and LULIBET of the defendant No.2 are both based on two different drugs/molecule. The plaintiff's product LABEBET contains molecule Labetalol whereas defendant's product LULIBET contains Luliconazole. The prefixes in both the competing marks LABEBET and LULIBET are totally different, distinct structurally, phonetically and visually and represent the name of totally different drugs/molecule. Further the plaintiff's product LABEBET is in tablet form to be administered orally or intravenously in injectable forms for ailment relating to hypertension while defendant's product LULIBET is in cream, lotion or spray form which is essentially meant for application on skin having external use only. The prefix 'LULI' is derived from the molecule Luliconazole and suffix 'BET' has reference to the apt bet to eradicate the fungal infection. It is pleaded that it is a common methodology and prevalent practice in the pharma industry to name medicines/products by using a combination of an abbreviation of the molecule with any such other name. It is common to name a product on the basis of the molecule/ basic drug/ salt name. It is also pleaded that there are large number of companies, manufacturers and marketers of Luliconazole who use the prefix LULI, details of which are given.
13. Hence, it is pleaded that adoption of the name LULIBET by the defendant is clearly honest and bonafide without any connection with the plaintiff's mark LABEBET. There is no similarity between the two marks. It is further stated that the two marks are phonetically and visually different.
14. It is further pleaded that defendant No.2 commenced production of its product in July 2016 onwards. The same was within the express knowledge of the plaintiff especially so as the plaintiff itself is marketing and selling a product containing the drug Luliconazole. Hence, it is pleaded that the present suit suffers from the vice of delay, latches and estoppel.
Defendant No.2 also applied for registration of the trademark LULIBET on 30.05.2016 and 16.06.2016 in class 5. Plaintiff did not oppose the applications. The time for filing objections to the said application has expired. Hence, it is pleaded that the suit of the plaintiff is liable to be dismissed.
It is further pleaded that the plaintiff has failed to make out any case of infringement or even passing off against defendant No.2. It is further pleaded that the plaintiff's own mark LABEBET is not a coined word but merely based upon/derived from the active ingredient Labetalol. It is further pleaded that large number of companies have trademarks with the prefix 'LABE' for their products containing Labetatol as the active ingredient. The said fact itself disentitles the plaintiff from making out any case of infringement or passing off against defendant No.2.
Further the abbreviation 'BET' cannot be usurped and monopolised by the plaintiff.
Similarly, as stated, there are many companies using the prefix LULI for the respective products. Hence, the plaintiff cannot claim any exclusive right over the prefix LULI since it is publici juris.
15. Defendant No.1 has also filed his written statement where it has supported the stand of defendant No.2.
16. I have heard learned counsel for the parties. Learned counsel for plaintiff submits as follows:-
(i) Plaintiff is a registered proprietor of the mark LABEBET in class 5 for medicinal and pharmaceutical preparations and is entitled to the exclusive right of using the same by virtue of section 28 of the Act. Plaintiff has statutory as well as common law rights. Any mark identical or deceptively similar to the plaintiff's trademark LABEBET would constitute infringement of the plaintiff's trademark.
(ii) It is pleaded that the defendant's trademark LULIBET when compared as a whole is structurally, phonetically and deceptively similar to the plaintiff's trademark LABEBET. They are sold through chemist shops. The competing marks have similar wordings as the first syllable and suffixes are identical. Hence, confusion and deception is likely when the test of imperfect recollection is applied to them. Reliance is placed on a large number of judgments to support the aforesaid submissions.
(iii) The use of the impugned mark LULIBET by the defendant constitutes infringement of the plaintiff's trademark LABEBET under section 29 of the Act. It is pleaded that the mark of the plaintiff is registered in class 5 which deals in medicinal and pharmaceutical preparations and substances and is not related to pharmaceutical preparations for ailment of hypertension only. Further, the possibility of patients with ailment of fungal infections consuming plaintiff's tablet LABEBET or being treated with an injection of the plaintiff cannot be ruled out. Reliance is placed on the judgment of the Supreme Court in the case of Cadilla Health Care Ltd. vs. Cadilla Pharmaceuticals Ltd., AIR 2001 SC 1952 and judgment of the Division Bench of this Court in The Himalaya Drug Company vs. M/s. S.B.L. Limited, 2013 53 PTC 1 Delhi (DB) to plead the case of the plaintiff.
(iv) It is further pleaded that defence of the defendant that there exist third party registration/use of deceptively similar mark by such third party is an argument which is misplaced and misconceived. It is pleaded that the plaintiff's right under section 28 of the Act have to be enforced by the court if the mark is deceptively similar/identical to the registered trademark. Merely because there are other marks that are deceptively similar and the plaintiff has not taken any action against them does not in any manner help the case of the defendant. Reliance is placed on the judgment of this Court in the case of Pankaj Goel vs. M/s Dabur India Ltd., 2008 (38) PTC 49 Delhi, and judgement of the Supreme Court in National Bell Company & Anr. vs. Metal Goods Manufacturing Private Limited & Anr., (1970) 3 SCC 665.
(v) Based on the above, it is pleaded that a decree of permanent injunction may be passed in favour of the plaintiff and against the defendants as sought for.
17. Learned senior counsel for defendant No.2 has pleaded as follows:-
(i) Defendant No.2 has applied for registration of the mark LULIBET on 30.5.2016. The application was duly published in the Trademarks Journal on 31.10.2016. The application of the defendants was not opposed by the plaintiff. Hence, the plaintiff cannot now seek an injunction on account of their conduct.
(ii) It is repeated that the trademark of the plaintiff LABEBET is derived from the molecule Labetatol and is used in the form of tablet/ injection for hypertension. The product of the defendant under the trademark LULIBET is derived from Luliconzole and is used externally as a lotion/cream for fungal treatment. On 22.3.2018 it is pleaded that defendant No.2 has already undertaken not to manufacture or market any product under the mark LULIBET in its tablet/ injectable form. It is pleaded that this would be a critical factor to refuse injunction to the plaintiff. Reliance is placed on the judgment of a co-ordinate Bench of this court in Kalindi Medicure Private Limited vs. Infra Pharmaceuticasl Limited, (2007) 136 DLT 200.
(iii) Defendant's mark LULIBET is not similar to or identical to the plaintiff's mark LABEBET. A bare comparison of the two marks indicates that the same are not identical or similar. As the marks are not identical or similar the test for infringement is the same as the test for passing off. It is reiterated that there is no likelihood of any deceptive similarity between the product of the defendant No.2 and the plaintiff's product.
(iv) Learned senior counsel further submits that LULIBET contains the molecule Luliconzole and hence the prefix LULI is derived from the molecule Luliconzole. It is a common practice under the pharma industry to name the mark and the brand names on such basis. Further, it is pleaded that large number of companies use the prefix LULI. Hence, it is pleaded that the plaintiff cannot claim any exclusive right to the prefix LULI since it is publici juris. Further, plaintiff's own mark LABEBET is not a coined word but merely based upon/derived from the active ingredient Labetatol. There are large number of companies having trademark with the prefix LABE for their products containing Labetatol.
(v) There is no phonetic similarity between the plaintiff's trademark and the defendant's mark. Merely because there is a commonality of the suffix BET does not amount to phonetic similarity. It is pleaded that the marks have to be compared as a whole and parts of the marks cannot be dissected to ascertain similarity between the two marks. Mere commonality of the suffix BET cannot ascribe any phonetic similarity between the two marks.
(vi) It is further pleaded that there is no confusion reported till date between the product of defendant No.2 and the product of plaintiff. No such complaint has been received from any such stakeholder. Hence, it is pleaded that the present suit is only an attempt to stop the progress of the defendant's drug.
(vii) It is further pleaded that the products of the defendant was launched in July 2016. There is gross delay on the part of the plaintiff in instituting this litigation and any injunction, at this stage, would prejudice defendant No.2. The application for registration of defendant No.2 was filed in July 2016 and was known to the plaintiff. The plaintiff has chosen to sit idle for 1 years and has not taken any action. Plaintiff is guilty of acquiescence, delay and latches.
18. I may first look at the contention of the plaintiff that the trademark used by the defendants LULIBET is deceptively similar to that of the plaintiff's trademark LABEBET and is an infringement of the rights of the plaintiff.
19. Reference may be had to sections 28 and 29(1) of the Trade Marks Act, 1999, which read as follows:
"28. Rights conferred by registration.—
(1) Subject to the other provisions of this Act, the registration of a trade mark shall, if valid, give to the registered proprietor of the trade mark the exclusive right to the use of the trade mark in relation to the goods or services in respect of which the trade mark is registered and to obtain relief in respect of infringement of the trade mark in the manner provided by this Act.
(2) The exclusive right to the use of a trade mark given under sub-section (1) shall be subject to any conditions and limitations to which the registration is subject.
(3) Where two or more persons are registered proprietors of trade marks, which are identical with or nearly resemble each other, the exclusive right to the use of any of those trade marks shall not (except so far as their respective rights are subject to any conditions or limitations entered on the register) be deemed to have been acquired by any one of those persons as against any other of those persons merely by registration of the trade marks but each of those persons has otherwise the same rights as against other persons (not being registered users using by way of permitted use) as he would have if he were the sole registered proprietor.
29. Infringement of registered trade marks.—
(1) A registered trade mark is infringed by a person who, not being a registered proprietor or a person using by way of permitted use, uses in the course of trade, a mark which is identical with, or deceptively similar to, the trade mark in relation to goods or services in respect of which the trade mark is registered and in such manner as to render the use of the mark likely to be taken as being used as a trade mark. …"
20. Reference in this context may be had to the judgment of the Supreme Court in the case of Kaviraj Pandit Durga Dutt Sharma v. Navratna Pharmaceutical Laboratories, AIR 1965 SC 980. The court held as follows:
"28. The other ground of objection that the findings are inconsistent really proceeds on an error in appreciating the basic differences between the causes of action and right to relief in suits for passing off and for infringement of a registered trade mark and in equating the essentials of a passing off action with those in respect of an action complaining of an infringement of a registered trade mark. We have already pointed out that the suit by the respondent complained both of an invasion of a statutory right under Section 21 in respect of a registered trade mark and also of a passing off by the use of the same mark. The finding in favour of the appellant to which the learned counsel drew our attention was based upon dissimilarity of the packing in which the goods of the two parties were vended, the difference in the physical appearance of the two packets by reason of the variation in the colour and other features and their general get-up together with the circumstance that the name and address of the manufactory of the appellant was prominently displayed on his packets and these features were all set out for negating the respondent's claim that the appellant had passed off his goods as those of the respondent. These matters which are of the essence of the cause of action for relief on the ground of passing off play but a limited role in an action for infringement of a registered trade mark by the registered proprietor who has a statutory right to that mark and who has a statutory remedy for the event of the use by another of that mark or a colourable imitation thereof. While an action for passing off is a Common Law remedy being in substance an action for deceit, that is, a passing off by a person of his own goods as those of another, that is not the gist of an action for infringement. The action for infringement is a statutory remedy conferred on the registered proprietor of a registered trade mark for the vindication of the exclusive right to the use of the trade mark in relation to those goods" (Vide Section 21 of the Act). The use by the defendant of the trade mark of the plaintiff is not essential in an action for passing off, but is the sine qua non in the case of an action for infringement. No doubt, where the evidence in respect of passing off consists merely of the colourable use of a registered trade mark, the essential features of both the actions might coincide in the sense that what would be a colourable imitation of a trade mark in a passing off action would also be such in an action for infringement of the same trade mark. But there the correspondence between the two ceases. In an action for infringement, the plaintiff must, no doubt, make out that the use of the defendant's mark is likely to deceive, but where the similarity between the plaintiff's and the defendant's mark is so close either visually, phonetically or otherwise and the court reaches the conclusion that there is an imitation, no further evidence is required to establish that the plaintiff's rights are violated. Expressed in another way, if the essential features of the trade mark of the plaintiff have been adopted by the defendant, the fact that the get-up, packing and other writing or marks on the goods or on the packets in which he offers his goods for sale show marked differences, or indicate clearly a trade origin different from that of the registered proprietor of the mark would be immaterial; whereas in the case of passing off, the defendant may escape liability if he can show that the added matter is sufficient to distinguish his goods from those of the plaintiff.
29. When once the use by the defendant of the mark which is claimed to infringe the plaintiffs mark is shown to be "in the course of trade" the question whether there has been an infringement is to be decided by comparison of the two marks. Where the two marks are identical no further questions arise; for then the infringement is made out. When the two marks are not identical, the, plaintiff would have to establish that the mark used by the defendant so nearly resembles the plaintiffs registered trade mark as is likely to deceive or cause confusion and in relation to goods in respect of which it is registered (Vide Section 21). A point has sometimes been raised as to whether the words "or cause confusion" introduce any element which is not already covered by the words "likely to deceive" and it has sometimes been answered by saying that it is merely an extension of the earlier test and does not add very materially to the concept indicated by the earlier words "likely to deceive". But this apart, as the question arises in an action for infringement the onus would be on the plaintiff to establish that the trade mark used by the defendant in the course of trade in the goods in respect of which his mark is registered, is deceptively similar. This has necessarily to be ascertained by a comparison of the two marks-the degree of resemblance which is necessary to exist to cause deception not being capable of definition by laying down objective standards. The persons who would be deceived are, of course, the purchasers of the goods and it is the likelihood of their being deceived that is the subject of consideration. The resemblance may be phonetic, visual or in the basic idea represented by the plaintiffs mark. The purpose of the comparison is for determining whether the essential features of the plaintiff's trade mark are to be found in that used by the defendant. The identification of the essential features of the mark is in essence a question of fact and depends on the judgment of the Court based on the evidence led before it as regards the usage of the trade. It should, however, be borne in mind that the object of the enquiry in ultimate analysis is whether the mark used by the defendant as a whole is deceptively similar to that of the registered mark of the plaintiff."
21. Reference may also be had to be judgment of the Supreme Court in the case of Amritdhara Pharmacy vs. Satya Deo Gupta, AIR 1963 SC 449 where the Court held as follows:-
"8. We agree that the use of the word "dhara" which literally means "current or stream" is not by itself decisive of the matter. What we have to consider here is the overall similarity of the composite words, having regard to the circumstance that the goods bearing the two names are medicinal preparations of the same description. We are aware that the admission of a mark is not to be refused, because unusually stupid people, "fools or idiots", may be deceived. A critical comparison of the two names may disclose some points of difference, but an unwary purchaser of average intelligence and imperfect recollection would be deceived by the overall similarity of the two names having regard to the nature of the medicine he is looking for with a somewhat vague recollection that he had purchased a similar medicine on a previous occasion with a similar name. The trade mark is the whole thing-the whole word has to be considered. In the case of the application to register "Erectiks" (opposed by the proprietors of the trade mark "Erector") Farwell, J., said in William Bailey (Birmingham) Ltd. Application [(1935) 52 RPC 137]:
"I do not think it is right to take a part of the word and compare it with a part of the other word; one word must be considered as a whole and compared with the other word as a whole…. I think it is a dangerous method to adopt to divide the word up and seek to distinguish a portion of it from a portion of the other word."
9. Nor do we think that the High Court was right in thinking that the appellant was claiming a monopoly in the common Hindi word "dhara". We do not think that that is quite the position here. What the appellant is claiming is its right under Section 21 of the Act, the exclusive right to the use of its trade mark, and to oppose the registration of a trade mark which so nearly resembles its trade mark that it is likely to deceive or cause confusion."
22. Reference may also be had to the judgment of the Supreme Court in the case of Cadila Health Care Limited v. Cadila Pharmaceuticals Ltd., AIR 2001 SC 1952. In that case some of the relevant facts were that the appellant had filed a suit for injunction against the respondent in relation to a medicine being sold by the respondent under the brand name 'Falcitab' which, according to the appellant, was said to be a brand name similar to the drug being sold by the plaintiff under its brand name 'Falcigo'. In that context, the Supreme Court held as follows:
"6. The respondent Company stated in the defence that the word "Falci", which is the prefix of the mark, is taken from the name of the disease "Falcipharum Malaria" and it is a common practice in pharmaceutical trade to use part of the word of the disease as a trade mark to indicate to the doctors and chemists that a particular product/drug is meant for a particular disease. It was also the case of the respondent that admittedly the two products in question were Schedule 'L' drugs which can be sold only to the hospitals and clinics with the result that there could not even be a remote chance of confusion and deception. It may here be noticed that Schedule 'H' drugs are those which can be sold by the chemist only on the prescription of the doctor but Schedule 'L' drugs are not sold across the counter but are sold only to the hospitals and clinics.
14. In Amritdhara Pharmacy v. Satya Deo Gupta [AIR 1963 SC 449] the respondent had applied for the registration of the trade name "Lakshmandhara" in respect of a medicinal preparation for the alleviation of various ailments. This was opposed by the appellant whose trade name "Amritdhara" had already been registered in respect of similar medicinal preparation. The question, which arose, was whether the name "Lakshmandhara" was likely to deceive the public or cause confusion to the trade. While interpreting Sections 8 and 10 of the Trade Marks Act, this Court observed at pp. 452-54 as follows: (AIR paras 7-9)
"7. It will be noticed that the words used in the sections and relevant for our purpose are 'likely to deceive or cause confusion'. The Act does not lay down any criteria for determining what is likely to deceive or cause confusion. Therefore, every case must depend on its own particular facts, and the value of authorities lies not so much in the actual decision as in the tests applied for determining what is likely to deceive or cause confusion. On an application to register, the Registrar or an opponent may object that the trade mark is not registrable by reason of clause (a) of Section 8, or sub-section (1) of Section 10, as in this case. In such a case the onus is on the applicant to satisfy the Registrar that the trade mark applied for is not likely to deceive or cause confusion. In cases in which the tribunal considers that there is doubt as to whether deception is likely, the application should be refused. A trade mark is likely to deceive or cause confusion by its resemblance to another already on the register if it is likely to do so in the course of its legitimate use in a market where the two marks are assumed to be in use by traders in that market. In considering the matter, all the circumstances of the case must be considered. As was observed by Parker, J. in Pianotist Co.'s Application, Re [(1906) 23 RPC 774] which was also a case of the comparison of two words—
'You must take the two words. You must judge them, both by their look and by their sound. You must consider the goods to which they are to be applied. You must consider the nature and kind of customer who would be likely to buy those goods. In fact you must consider all the surrounding circumstances; and you must further consider what is likely to happen if each of those trade marks is used in a normal way as a trade mark for the goods of the respective owners of the marks.' (p. 777)
For deceptive resemblance two important questions are: (1) who are the persons whom the resemblance must be likely to deceive or confuse, and (2) what rules of comparison are to be adopted in judging whether such resemblance exists. As to confusion, it is perhaps an appropriate description of the state of mind of a customer who, on seeing a mark thinks that it differs from the mark on goods which he has previously bought, but is doubtful whether that impression is not due to imperfect recollection. (See Kerly on Trade Marks, 8th Edn., p. 400.)
33. ….
What is likely to cause confusion would vary from case to case. However, the appellants are right in contending that where medicinal products are involved, the test to be applied for adjudging the violation of trade mark law may not be on a par with cases involving non-medicinal products. A stricter approach should be adopted while applying the test to judge the possibility of confusion of one medicinal product for another by the consumer. While confusion in the case of non-medicinal products may only cause economic loss to the plaintiff, confusion between the two medicinal products may have disastrous effects on health and in some cases life itself. Stringent measures should be adopted specially where medicines are the medicines of last resort as any confusion in such medicines may be fatal or could have disastrous effects. The confusion as to the identity of the product itself could have dire effects on the public health."
23. I may now come to the facts of this case. The plaintiff's trade mark is "LABEBET" whereas the trade mark of the defendant is "LULIBET". The marks have to be compared as a whole. They have to be judged by their look and their sound. The nature of customers who are likely to buy the goods has also to be considered in my opinion. If the two marks are compared as a whole the mark of the defendant is phonetically, visually and structurally, similar to that of the plaintiff. A person of average intelligence and imperfect recollection is likely to be deceived or confused. That apart as noted by the Supreme Court in Cadila Health Care Limited vs. Cadila Pharmaceuticals Ltd.(supra) where the medicinal products are involved the test to be applied would be stricter than should be applied for non medicinal products. In the case of non medicinal products, a confusion only creates economic loss but in the case of medicinal products, it may have adverse consequences on the health and life of the individual.
24. However, learned senior counsel for defendant No.2 has raised various issues to plead that likelihood of an average person being deceived or confused by the alleged similarity of the marks does not arise. It is also pleaded that other facts, even otherwise warrant that no interim order be passed by this court. I may now deal with some of the submissions raised by learned senior counsel for defendant No.2. It was firstly urged that the application of the defendant for registration of the mark LULIBET was published on 31.10.2016. However, no objections were filed by the plaintiff. The plaintiff cannot now turn around and urge that the mark of the defendant is deceptively similar to that of the plaintiff.
25. In my opinion, the plaintiff has given an adequate explanation for the fact as to why they did not oppose the trademark application filed by the defendant. It has been pleaded that when the trademark of the defendant was published, it escaped the attention of the plaintiff. However, it has rightly been pleaded that the fact that the plaintiff did not oppose the application of the defendant before the Trademark Registry does not mean that the defendant can continue to violate the trademark of the plaintiff in violation of the Act specially sections 28 & 29.
26. The other arguments raised by the learned senior counsel for the defendant were that the product of the defendant is used externally as a lotion/cream for fungal treatment. The admitted fact is that the plaintiff's preparation is not sold in the form of lotion/cream. The product of the plaintiff LABEBET is sold in the form of tablet/injectable form. The defendant on 22.03.2018 has already undertaken not to manufacture or market any product under the mark LULIBET in its tablet/injectable form.
27. It is also pleaded by the learned senior counsel for defendant No.2 that the mark LULIBET contains the molecule Luliconazole and hence the prefix LULI is derived from the said molecule. It is pleaded that this methodology is used to name the mark is prevalent and common in the pharma industry and various brands are coined on such basis. List of ten products are given with the prefix LULI including LULIFIN, LULICAN, LULIMAC etc. Similarly, it is pleaded that the plaintiff's mark LABEBET is not a coined word but merely based on salt/molecule derived from active ingredient Labetalol. Hence, there is no scope for deception. Reliance is also placed on judgment of a Co-ordinate Bench of this court in Kalindi Medicure Pvt. Ltd. vs. Intas Pharmaceuticals Ltd. & Anr.(supra) to support the plea that there is no likelihood of confusion.
28. The above plea is misplaced. It may be true that the fact that the plaintiff's drug is sold in the form of tablet/injectable form and the defendant's drug is sold through lotion/cream. However, it cannot be ignored that both the drugs are sold through a common retail shops. Further the similarity of the marks as noted above cannot completely rule the possibility of deception or confusion. As medicinal products are involved this court would have to adopt a stricter approach.
29. Reference may be had to the judgment, relied upon by the defendant, of this Court in the case of Kalindi Medicure Pvt. Ltd. vs. Intas Pharmaceuticals Ltd. & Anr.(supra). The plaintiff had sued for infringement of the trademark LOPRIN. The defendant had adopted the word LOPARIN. The court held as follows:
"33. Admittedly, both products are used for similar type of diseases, namely, treatment of heart ailment, but whereas LOPRIN is a preventive drug, LOPARIN is a curative drug. As pleaded by the plaintiff (refer para 9 of the plaint), LOPRIN is a coined word derived from 'low dose of aspirin' i.e. amalgamation of the word 'low' and the word 'aspirin', defendants mark LOPARIN is a coined word derived from Mow molecular weight heparin' and the molecule-Enoxaparin i.e. amalgamation of the word 'Low' and the word 'Enoxaparin'.
34. It cannot be ruled with certainty at this stage that defendant has resorted to a dishonest adoption.
35. In pharmaceutical trade, one finds names of various drugs almost similar to each other—having common prefix or suffix—for the reason the drug conveys what salt it is a derivative of.
36. No doubt, doctors can also err and it is not uncommon for drugs to be purchased over the telephone and even handwritten prescriptions may be misread due to bad handwriting, but method of intake of a drug by a person is not to be ignored.
37. Plaintiffs product is taken orally and is sold as a pill. Defendant's product is intramuscularly injected with aid of a syringe. Thus, other factors like nature of the product, design and get-up of packing, price, weight, etc. have necessarily to be given due recognition.
38. Factors listed by the defendants in paras 18 and 19 of the reply to IA No. 9988/06 are critical and, in my opinion, break the deadlock. LOPRIN is an anti-platelet drug and prevents coagulation. It is prescribed to prevent adverse cardiac events in patients who are at a risk. It is used by patients over a long period of time. Loparin is a critical care medicine used in acute coronary syndrome as an anticoagulant in emergency, normally used in Intensive Coronary Care Unit. It is administered subcutaneously or intravascularly. The former is sold as pills in aluminium foils, the latter is sold in prefilled syringe. Price difference is huge. Over 52 times.
39. A word on balance of convenience. Defendant has sales of nearby Rs. 8 crores in less than a year. The product is in the market since October, 2005. Ex facie, defendants have built a good market. Balance of convenience lies in favour of the defendants."
30. Hence, the court took a decision in the facts of that case taking into
Please Login To View The Full Judgment!
account the aspects, like product, design, get up, packaging, price etc. The court noted that LOPARIN is a critical care medicine used in acute coronary syndrome, in emergency, normally used in Intensive Coronary Care Unit. It is administered intravascularly. The price difference was also huge. Keeping in account the aforesaid facts, the court took the view that an interim injunction cannot be granted to the plaintiff. 31. In my opinion, the said judgment would not apply to the facts of this case inasmuch as noted above as the trademark of the defendant is phonetically, structurally and visually similar to the trademark of the plaintiff and this is likely to create confusion. In the facts of the case the possibility of deception or confusion being caused to a unwary purchaser of average intelligence and imperfect recollection cannot be ruled out. 32. The next plea raised by the learned senior counsel for defendant was that there was a delay in filing of the present injunction application. The product of the defendant was launched in July, 2016, but the present application was filed in November, 2017. It is pleaded that hence the plaintiff is guilty of delay and laches. 33. In this context, reference may be had to the judgment of the Supreme Court in Midas Hygiene Industries (P) Ltd. & Anr. vs. Sudhir Bhatia and Ors. (2004) 3 SCC 90 where the Supreme Court held as follows: "5. The law on the subject is well settled. In cases of infringement either of trade mark or of copyright, normally an injunction must follow. Mere delay in bringing action is not sufficient to defeat grant of injunction in such cases. The grant of injunction also becomes necessary if it prima facie appears that the adoption of the mark was itself dishonest." Hence, even if there was delay on the part of the plaintiff in filing of the present suit as has been claimed by the defendant, the same delay would not be sufficient to deter grant of injunction in favour of plaintiff. 34. The issue of delay and laches has also been dealt with by the judgment of a Co-ordinate Bench in the case of Kalindi Medicure Pvt. Ltd. vs. Intas Pharmaceuticals Ltd. & Anr.(supra). The court held as follows: 27. Relief of injunction being an equitable relief, delay becomes relevant but mere delay in bringing an action for infringement of a trademark or for passing off is no ground for refusing an injunction. The grant of injunction becomes necessary if it prima facie appears that the adoption of the mark was dishonest [See 2004 (28) PTC 121 (SC), Midas Hygiene Industries Pvt. Ltd. v. Sudhir Bhatia]. 28. Acquiescence by itself is also no ground to non suit a plaintiff, if otherwise his claim is found to be genuine. In Willmott v. Barber, (1880) 15 Ch.D. 96 Fry, J. said: "It has been said that the acquiescence which will deprive a man of his legal rights must amount to fraud and in my views this is an abbreviated statement of a very true proposition. A man is not to be deprived of his legal rights unless he has acted in such a way as would make it fraudulent for him to set up those rights." 29. Acquiescence is nothing but one facet of delay. If a plaintiff stands by knowingly and lets a defendant build up an important trade until it has became necessary to crush it, the plaintiff would be stopped by acquiescence. It would be a fraudulent conduct to allow knowingly somebody to spend money to build a reputation and then try and crush it. 30. It is important to distinguish between mere negligence and acquiescence as was observed by Sr. John Romilly in Harcourt v. White, 28 Bear 303. As Explained in Power Control Appliances v. Sumeet Machines Pvt. Ltd., J.T. 1994 (2) SC 70 (Para 29) acquiescence is sitting by when another is invading the rights and spending money on it. It is a course of conduct inconsistent with the claim for exclusive rights in a trade mark. It implies positive acts, not mere silence or inaction such as is involved in laches. The observations are another form of knowingly sitting idle." 35. In the facts of this case it cannot be said that the plaintiff stood by knowingly and let the defendant build up its business. There is no merit in this plea. 36. In view of the stated legal position, in my opinion, no grounds are made out for refusing an injunction to the plaintiff. A decree of injunction is passed in favour of the plaintiff and against the defendant restraining the defendant's agents, dealers etc. from using the said trademark LULIBET or any other mark that is phonetically, structurally or visually similar to the plaintiff's trademark LABEBET. The plaintiff shall also be entitled to costs. The decree of permanent injunction shall be effective after two months from today. This period is being granted to enable the defendants to take appropriate remedial measures. 37. Suit stands disposed of. All pending applications, if any, also stand disposed of accordingly.


text:
Chelsea award winner set for exciting move after Prem club win fierce battle
Chelsea youngster Valentino Livramento is reportedly closing in on a move to Brighton following a fierce transfer battle for his services.
The 18-year-old raised his profile significantly last season by winning the Blues' Academy Player of the Year award. He scored two goals while assisting six others to help Chelsea finish second in the Premier League 2. Indeed, those performances came at Under-23 level, showing his confidence and ability.
Recent reports claimed that Chelsea 'feared' losing the starlet, because of the lack of faith they have shown in other young talent; Marc Guehi has signed permanently for Crystal Palace while Fikayo Tomori is staying at AC Milan.
Now, Goal reports that Brighton will likely win the race for right-back or right midfield star Livramento.
They only need to agree a fee with Chelsea, who could yet include a sell-on clause.
However, the Seagulls have done well to get to pole position for Livramento's transfer.
Southampton came in with a 'strong' late push, following Aston Villa, RB Leipzig and Milan showing interest.
Still, Chelsea and Brighton did business in January 2020 to allow Tariq Lamptey to move to the Amex Stadium.
Like Livramento, Lamptey plays at right-back at right wing-back and impressed in 2020/21.
Goal's report has also revealed that another Blues youngster, Myles Peart-Harris, is close to a move to Brentford.
The 18-year-old is another starlet Chelsea supposedly feared leaving. But he has seen the opportunity to get into a first team faster by joining the Premier League's new boys.
Elsewhere, Dynel Simeu – the third player named in the earlier report – is also inching towards a Premier League move. However, his destination remains unclear.
As for other fringe players on Chelsea's books, Genk only need to have a bid accepted as they chase a deal for Ike Ugbo.
Chelsea youngster sends Tuchel message
Conor Gallagher is another youngster who forms part of Chelsea's extensive collection of young talent.
The midfielder played at West Brom last season in what was his third loan spell, but his first in the Premier League.
He has begun pre-season with Chelsea's first team and told boss Thomas Tuchel of his plans for the upcoming campaign.
Second-season syndrome: Leeds on a mission to avoid fates of Sheff Utd, Huddersfield, Ipswich & Reading
The post Chelsea award winner set for exciting move after Prem club win fierce battle appeared first on TEAMtalk.

subset: commoncrawl


text:
- adidas Originals male sneaker
- Adidas is the original sports brand, Driven by innovation and a bias to action. We are creators, makers and doers
- No matter how serious you are about sports – a sporting Lifestyle does not end in the locker room
- We are creators, makers and doers
Details: adidas Originals male top ten rb shoes.
Binding: Apparel


text:
Arlington County will spend $17.6 million to design, build and oversee the construction of a building to wash, fuel, park and maintain its 60-bus fleet, the County Board unanimously decided Saturday.
The Arlington Transit bus maintenance facility will be built on the site of a county-owned lot at South Eads and 32nd St. in Crystal City, adjacent to a WMATA structure where buses are currently washed and fueled between 3 and 6 a.m. at a high cost, county officials said.
W.M. Schlosser Co. was awarded a $12.4 million construction contract, which will start this summer and take 18 months to complete. Another $5.2 million will be needed for design, construction management and related costs, officials said. Part of the plan is to improve the appearance of the property along Jefferson Davis Highway. Money for the project comes from a combination of state and regional funds and local commercial real estate tax revenue that can only be used for transportation.
The building will not be able to handle "heavy" maintenance, which will continue to be done outside the county, nor will it house the existing fleet or the 30 additional buses expected to be in use by 2022.
The ART buses, started to supplement WMATA's Metrobus service, have seen ridership grow from 650,000 in 2004 to nearly 3 million this year.
A county facilities study now underway is looking for places to park those additional buses, as well as public school buses. The county just last week announced plans to buy six acres of land near Washington-Lee High School that might be used in part for that purpose.
Another major county construction project, the $9 million homeless services center, has fallen months behind schedule, and the County Board agreed Saturday to spend another $116,842 to oversee its continued work. Like the bus facility decision, the shelter delay attracted no discussion from the County Board nor from the public.
The homeless shelter, which is supposed to occupy two floors of a renovated commercial building at 2020 14th St. North in the Court House neighborhood, was supposed to have been finished in March. A previously announced completion date of June will also be missed, said County Manager Barbara Donnellan, who visited the site Friday.
"No one is more disappointed than me because I wanted this to be done before I leave," she said. Donnellan is retiring at the end of June.
The construction contractor is being charged $1,250 per day he is late, Donnellan said, and that money along with the project's contingency funds will pay for the additional construction oversight that is needed.
The cost of renovating the other four floors of the building for county offices (first-floor retail space will be retained) is not included in the construction cost. The total cost of buying the building, renovation and relocation was in 2012 expected to be $37 million.


text:
Ask About Our New Customer Discount!
Ask About Our New Customer Discount!
We strive to provide excellent customer service and to make the bail bond process as easy and comfortable as possible.
We know when a loved one is arrested and taken to jail it can be a difficult time and we want to be there for you. Our friendly, knowledgeable staff are available 24 hours per day 7 days a week to help with with all of your bail bond needs.
OUTLAW BAIL BONDS is Houston's premier bonding company. We specialize in Non Arrest bonds and are always available to help keep you out of jail ! We take pride in the service we provide and are happy to answer any questions you may have.
If you are looking for an affordable bonding company that you can trust, give us a call anytime, 24 Hours per day 7 days a week.
We will be there when you need us most.
Outlaw Bail Bonds - License 74435
12724 Woodforest Blvd, Houston, TX 77015, US
Copyright © 2022 Outlaw Bail Bonds - All Rights Reserved.
Powered by GoDaddy


text:
Most people think that driving is the same regardless of the season. However, there are some key differences between driving in summer and driving in winter. Here are a few things to keep in mind:
Automobiles: In winter, it is important to make sure your automobile is properly serviced and in good working condition. This means having the right tires for the season, as well as making sure all your fluids are topped off. In summer, you may not need to worry as much about your car's maintenance, but it is still important to keep an eye on things.
Driving: In general, you should drive more slowly and carefully in winter weather conditions. This means being extra aware of ice and snow on the road, and giving yourself more time to brake. In summer, you can typically afford to drive a bit faster and be less cautious. However, you should still be aware of potential hazards on the road, such as potholes or animals.
Season: The type of season can have a big impact on your driving. Summer is typically the best time to drive, with good weather conditions and longer days. Winter can be more challenging, with shorter days and potentially hazardous weather conditions.
Overall, it is important to be aware of the differences between driving in summer and driving in winter. By doing so, you can help keep yourself safe on the road no matter what the season may be.
Although drivers may believe that driving a car is the same all year, seasoned drivers are more likely to be aware that winter and summer provide distinct delights and difficulties. The most obvious distinctions between seasons are temperature, precipitation, and hours of sunshine.
But each of these can affect driving conditions in different ways. In winter, colder temperatures make it more difficult to keep your car running efficiently. Your engine will take longer to warm up, and you may find yourself making more frequent stops for gas. You'll also want to be sure to have your tires properly inflated and check your battery regularly. Winter weather can also create hazardous driving conditions, so it's important to take things slow and be extra cautious when behind the wheel.
Summertime brings its own unique set of challenges for drivers. The heat can take a toll on your car, causing the engine to overheat or the tires to wear down faster. It's also important to stay hydrated when driving in hot weather, as dehydration can lead to fatigue. And of course, there's the increased risk of accidents due to more people being on the road for vacation.
Whether you're driving in winter or summer, it's important to be aware of the unique challenges each season presents. By taking a few extra precautions, you can help ensure a safe and enjoyable driving experience no matter what the weather brings.
There are numerous factors that may alter driving conditions significantly. Some drivers even avoid operating in bad weather for fear of accidents. Both seasons, however, have benefits, so drivers can drive if they know how to take advantage of them.
One of the most significant dangers in winter driving is the increased chance for black ice. This is especially prevalent on bridges and overpasses where ice can form even when the rest of the road is clear. Black ice is nearly impossible to see, so if a driver hits it, they could easily lose control of their vehicle.
To avoid black ice, drive slowly and carefully, especially at night or in areas where ice is more likely to form. Winter tires are also helpful as they provide better traction on icy roads. If you do hit black ice and start to slide, take your foot off the accelerator and steer into the direction of the skid.
In contrast to winter driving, summer driving generally means warmer weather and milder conditions. However, this doesn't mean that summer driving is without its dangers. One of the most common dangers of summer driving is heat stroke. This can happen when a driver is exposed to high temperatures for a prolonged period of time, leading to dehydration and eventually loss of consciousness.
To avoid heat stroke, make sure to drink plenty of fluids and take breaks often if you're going to be driving in hot weather. It's also important to stay cool inside your car by using the air conditioning and opening the windows occasionally to let fresh air in.
Both winter and summer driving come with their own set of challenges, but by taking the proper precautions, drivers can enjoy the road no matter what the season.
It's important to be cautious in the summer heat. The sun's rays are harmful, so motorists should use sunglasses or lower visors. Hot, humid weather may lead to windows fogging up. Using air conditioning to keep passengers and pets comfortable is frequently a good idea. When vehicles are left in the sun for an extended period of time, melted crayons or other plastic toys may be found inside.
In winter, drivers must take care to clean off all the snow and ice from their car before driving. This includes the roof, hood, trunk, windows, windshield, wipers, and headlights. It's also important to clear any snow that may have blown up under the car. Failing to do so can result in a ticket.
If you live in an area that gets a lot of snow, you should also invest in a good set of snow tires. These will help improve your traction on icy roads.
Finally, always make sure you have a full tank of gas before heading out on a winter road trip. Running out of gas in the middle of a blizzard is not fun.
During the winter, rain, dark skies, hail, or snow storms are certain to put even the most experienced drivers to the test. During showers or thick fog, drivers may experience limited visibility, which necessitates them to decrease speed or wait it out. Chains might be required due in part to special equipment such as this. Another issue is that cars can freeze overnight if parked outside for an extended period of time. Drivers must also be wary of icy roads that could cause skidding and accidents.
In contrast, driving in the summer can be much more enjoyable. The days are longer, providing more visibility on the roads. The weather is typically warmer and drier, making it easier to handle car troubles that may arise. However, drivers must still be cautious of potential hazards such as construction projects or animals crossing the road.
Whether driving in winter or summer, it is important to be aware of the unique challenges that each season brings. By being prepared and taking extra care while behind the wheel, drivers can stay safe all year round.


text:
News and Updates
First Quarter 2022
January 3, 2022
RiskTool has not been impacted by the Apache Log4j vulnerability
We know you're busy, so we'll get straight to the point: RiskTool is not impacted by the Apache Log4j vulnerability.
If you're not familiar with this vulnerability and are interested in learning more, keep reading....
You may have heard that on Thursday, December 9th, an exploit in the popular Java logging library Apache Log4j was discovered potentially allowing a remote attacker to gain access and control to systems using the library. (CISA guidance)
RiskTool Technologies has performed an in-depth analysis of its internal systems and codebase and has taken any necessary action to patch potential vulnerabilities related to this exploit. In addition, we performed a thorough review of security audit logs and verified there were no indicators of attempts to exploit this vulnerability against RiskTool services.
At this time, we are confident that the RiskTool product has not been impacted by this vulnerability. The security of our product and our customer's data is our top priority. This has our highest level of attention and we are dedicated to continuously monitoring new information from vendors and other sources. We will provide more updates, if necessary.
If you have any questions or concerns, please call us at 877-700-2332 or email firstname.lastname@example.com
Thank you,
The RiskTool Technologies Team


text:
Barjees assures mountaineers safe travel, climbing activities in GB
Islamabad, Oct 1: Minister for Kashmir Affairs and Gilgit-Baltistan Chaudhry Barjees Tahir on Tuesday assured the international mountaineers and tourists of all possible measures for their safe and secure travel and climbing activities in GB. "In June this year an unfortunate incident of terrorist attack occurred at the Diamer Base Camp of Nanga Parbat. As Minister Incharge of Gilgit-Baltistan, I take this opportunity to assure the international mountaineering community that the Government of Pakistan is ensuring all possible measures for their safety," he said while addressing the concluding session of a two-day general council meeting of the Union of Asian Alpine Association (UAAA).
The meeting was organized by Alpine Club of Pakistan (ACP) here.
The minister termed the meeting a significant gathering of mountaineering community from Asian countries, which he hoped, would help promote mountaineering and tourism in Pakistan, blessed with the most unique landscapes, adorned plains, beaches, deserts and mountains.
It is Gilgit-Baltistan where three gigantic and spectacular mountain ranges of the world namely, Karakoram, Hindukush and Himalyas meet, boasting one of the richest collection of high peaks on earth, including the five peaks rising above 8,000 metres, topped by the second highest rocky pyramid – Chogori, the K2, he said. "Besides high mountains, there are numerous glaciers longest outside the polar region," he added. He said, "The enchanting and luring valleys of Hunza, Shigar, Khaplu, Ghizer and Astore adorned by crystal blue lakes have lured tourists from all over the world. In short Gilgit-Baltistan can well be called a paradise on earth for mountaineers, adventure seekers and nature lovers."
Meanwhile, the two-day meeting of the UAAA ended with a pledge to make concerted efforts to preserve environment while promoting mountaineering in the Asian region.
As many as 27 delegates from eight Asian countries attended the UAAA General Council meeting.
The meeting, besides discussing environmental protection and ecological conservation of mountains and forestry, also re-elected Dr In-Jeong Lee President of UAAA for another term. (APP)
The meeting, besides discussing environmental protection and ecological conservation of mountains and forestry, also re-elected Dr In-Jeong Lee President of UAAA for another term. (APP)


text:
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
To help your fish reach their peak coloration you need a fish food to unleash their full potential. YFS Red Supreme color pellets are the perfect food to bring out those natural red, orange, blue and yellow pigments. Say goodbye to dull drab fish and hello to bright vibrant colors.
Loaded with shrimp and spirulina, plus extra doses of astaxanthin, canthaxanthin, paprika and marigold to bring out the reds, orange and yellows. The addition of fish meal, squid and kelp along with all the necessary vitamins and minerals for proper growth and health makes this a daily staple food as well.
✔ No Artificial Coloring Added - We help your fish achieve their brightest, beautiful looks through natural ingredients and also by adding astaxanthin, canthaxanthin, paprika, and marigold.
✔ Small Batch Production - By creating our fish foods in small batches, we're able to ensure a level of quality that other fish foods simply can't match.
✔ Manufactured in the USA - With high-quality ingredients grown and processed in the US and USA manufacturing, we're involved with every step of the process to give your fish the quality they deserve.
Nutritional InfoIngredients
- Herring Meal, Shrimp Meal, Squid Meal, Wheat, Kelp Meal, Soy Protein, Fish Oil, Spirulina, Chlorella Algae, Dried Yeast, Paprika, Garlic, Marigold, Astaxanthin, Beta Carotene, Canthaxanthin, with added vitamins and minerals.
- 45% Protein 8% Fat 3% Fiber 12% Moisture
Great service!
I order the wrong food they corrected, stopped shipment at post office, and sent the new order out in one day!
Fish find them tasty
My goldfish and loaches gobble up these sinking pellets. They sink slowly enough that mid-water eaters can grab them, and then some reach the bottom for the bottom feeders. Interestingly, even my large goldfish prefer the smallest size to the medium size. These were also my betta's preferred food; if I placed them carefully on the surface of the water, they floated there until he grabbed them.
Looking forward to using
I am looking forward to using the Red Color Pellets. Last year I was using the Tropical Pellets and the Koi loved them, so I hope the Koi enjoys these too.
Cichlid pellet
You say it does not cloud water but it does.
Shopping experience
Great experience.


text:
Kerish Doctor Crack Updated fresh
We want to present to you, dear readers, the news about the new version of crack kerish doctor 2022.
All old versions of the program will be removed from the web-site.
The application provides high-quality maintenance for your computer. It also regularly checks your system registry and uninstalls dangerous programs and temporary files. The program has an advanced text mode and can be easily switched between that and the usual windows interface. All operations can be managed via the intuitive interface. Due to its integrated activation, Kerish Doctor also works fast and saves you time.
Other features include a full-featured user interface, which allows you to access important function from a single window and customized parameters. The repair-pc function includes the latest technology to diagnose and repair your PC, even when it has multiple issues. When you buy the crack kerish doctor 2022 Registration Code, the system will check all of your windows registry and then delete the problem contents.
Kerish Doctor Setup Free download is compatible with any operating system, including Windows 7, Vista, 8, 8.1, 10. Even, 10/10/2019, Kerish Doctor Crack Free download is compatible with the Windows versions. It can be used on any version of Windows OS.
Kerish Doctor Crack restores and manages personal data, but also monitors your computer system and its components. This allows you to identify and resolve problems quickly and efficiently to avoid downtime or lost data.
Download Kerish Doctor Full Repack Last version
Unlike the majority of other programs, Kerish Doctor does not allow you to leave behind the details related to its installation. This will enable the crack kerish doctor 2022 to serve you better in the future.
'Kerish Doctor' is one of the important applications, which appears in the list of programs as 'crack kerish doctor 2022' and is the actual name of the main program of Kerish Doctor 'crack kerish doctor 2022'. The program is launched by default whenever you install Windows operating system and the application is also installed.
If you want to permanently remove Kerish Doctor from your computer, you can do this manually by going to Start Menu > Control Panel > Programs > crack kerish doctor 2022 and then delete the application from here. This process will also uninstall Kerish Doctor for both 32bit and 64bit Windows operating systems.
Windows XP users may be able to get the latest version of Kerish Doctor from the manufacturer's website. Kerish Doctor is available in all major download portals such as Windows Update, Softpedia, and direct download.
Sometimes, to improve one's voice and words, you need to de-accentuate them or, if this is not possible, to tone them down or, if not possible, to completely change them. What we recommend is not just changing words – these are not even only voice lessons – but to use another voice. This can be a pleasant, dreamy-sounding voice, but above all, in all of the samples, it is for the person's language.
In some cases, if the words are lost in their accent, it is also useful to add them if they occur in time, if the wording does not fit, and if the accent is not very intense. What we recommend is not just to get rid of the accent, but to impose different words. Thus you can return something that is completely harmless, but the speech will be less strong and you will get another voice.
What we recommend is to use several voices: it can be useful to use a lighter and more dreamy voice in the first part of the project, and then a manlier and stronger voice for closing the project or even finishing it.
Kerish Doctor Crack Latest update
The main menu in crack kerish doctor 2022 allows you to quickly check your PC, including your PC's hardware and registry information, your browser, installed applications, current running processes, and tasks not responding or running in the background.
Kerish Doctor can directly fix hardware problems, resolve invalid registry issues, and clean temporary files. In addition, you can eject external hard drives without restarting, clean USB and other attached storage devices, reformat the drive, or delete items from the disk drive and create the empty space without damaging the storage media. You also can restore the PC's original Windows 7 or Vista, clean the registry, and repair Windows Updates without any user interaction.
KerishDoctor Serial Number Tools include the most complete set of scans in the scanner. You can clean Internet history, cookies, temporary files, unused files, orphans, unwanted applications, Adware, and Cookies. However, it also includes the removal tools such as Adware, browser hijackers, duplicated processes, homepage hijackers, Java script, plug-ins, and spyware. This feature offers you to clean your system files, uninstallers, applications, files, and folders.
Kerish Doctor [Nulled] + Serial number FRESH
Kerish Doctor is a powerful software that has a clean and simple interface. The tool eliminates the clutter from your computer and keeps your disk free. Its tool for an effective cleaning process removes excessive digital junk without erasing or corrupting any important files on your computer. However, it does not change system registry and it works on a system level.
The application is equipped with a user-friendly interface that allows the end user to manually choose what to delete or keep. The application is compatible with Windows 10, 8.1, 8, 7, Vista, and XP operating systems.
With Kerish Doctor, you can also complete a thorough online backup of your computer data and files to protect them from getting lost. It does a quick scan of your PC system and also notifies you about the update of the registry.
The tool is a simple application with a clean interface, and it does not come with a lot of options. All it does is to show the user what he needs to do. Whether he wants to remove folders or files, it will ask for a few inputs and then proceed with the operation.
Kerish Doctor is a great package for an effective and efficient cleaning process for your computer. The tool manages to detect and remove all the temporary files and junk on the PC.
Do you want to make sure that your browser, operating system, and files are always up to date? crack kerish doctor 2022 is the best tool to always get everything updated and refreshed. The tool is an online service that provides weekly or monthly updates to the latest versions of your system and makes sure your computer always works fast. It has three parts, Search, Tools, and Services. Users can also download free trial versions before deciding to use it. You can navigate it using either the search box or search categories. It is a safe online service that does not require any software or account to access its features.
Are you planning to create an external hard drive for holding your data and other valuable files? If yes, then it is essential to make sure that your hard drive is always secure. Disk Doctor is the best tool to always have a fast, smart, and safe hard drive. It is a handy tool that enables you to make sure that your system is free of virus attack, malware, and crashes.
Kerish Doctor Features
Kerish Doctor is a popular application which has the ability to scan your PC and has the capability to do all possible things that can happen on a Windows Operating system. The process of removing Kerish Doctor is simple and quick. No additional steps are required and it will show a window that will contain the necessary instructions.
Kerish Doctor is one of the fastest software to fix registry errors. The crack kerish doctor 2022 makes use of the registry cleaner, which can find windows registry errors on the operating system. If you want to speed up the execution time, then the version that was installed should be removed, and a newer, quicker version should be installed. In order to remove a version, the uninstaller will be required. This feature enables you to fix registry errors at once, on the computer itself. This will greatly improve the speed of your computer. That way, errors or problems, that have been made while the software was being used, can be fixed. You can also remove unnecessary files that have been created while using the software. It will also determine which parts of the registry have been damaged and whether it is necessary to rebuild the registry. If you want to remove unused programs, it will remove them from your computer.
Kerish Doctor has a comprehensive registry tool with more than 60,000 functions. You can use the tools to help you fix Windows problems, speed up the system, increase the performance and protect against malware and viruses.
Who Uses Kerish Doctor and Why Is It Important?
If you choose to not start Kerish Doctor, you can close it normally, which will not delete any files. However, it will still be running in the background. When you restart the computer, crack kerish doctor 2022 will start automatically.
We are a full-service voiceover and lip sync company, delivering high-quality voiceovers and lip sync for just about any project. Your voiceover requires a certain amount of features to make sure your call to action is clear and effective. Kerish Doctor allows us to select options to fine-tune your voiceover scripts. Our voiceover clients include web design companies, application developers, software publishers, e-commerce companies, customer service companies, corporate communication centers, marketing companies, web publishers, copywriters, and many more.
Kerish Doctor is a tool for writers and translators to automate and streamline their writing workflow. It is designed to help you cut through the noise. The workflow is divided into three streams: translation, copy, and optimization. In each stream, you specify a process in which to automate an action. You can edit text and markup with any supported document or web service, or create your own custom document. crack kerish doctor 2022 applies the automated workflow to your document.
Kerish Doctor is only available to licensed users. A subscription to Kerish Doctor includes access to all the features of the application. A subscription from $99 USD/year up to $4900 USD/year.
Poorly-written narration is never a good thing. Even for projects that target a culturally-neutral audience, a poor verbal performance by the narrator has the potential to alienate listeners. In their "plain english" blog, the team at Alconost reported that they had found that audio quality was the number one usability issue when testing voice applications for children. To attract and retain customers, we must deliver high-quality products and services to our clients. That's why it's important to have the best voiceover service available.
Kerish Doctor provides the best performing, highest quality voiceover and sound editing services for independent artists, filmmakers, animators, game developers, audiobook authors, documentary creators, podcast guests, and anyone who needs excellent voice performance.
We have clients in all of the major markets worldwide. Alconost can provide native-speaking voice actors for projects in both English and any of the foreign languages supported by crack kerish doctor 2022. We can provide on-line transcription, translation, narration, and sound editing services for your project or client.
Kerish Doctor has received numerous awards for its innovative approach to content delivery. For example, we have been awarded the highest honor a voiceover service can receive for our content delivery service:
HDD Regenerator Full Nulled + [Serial Key] [NEW]
What's new in Kerish Doctor?
The present version of Kerish Doctor – 1.9.0 – is a far better version than previously. It even will certainly get rid of each and every threat by using a PC, without a loss of data or corrupting data. In addition, it enables you to enhance the performance of your computer by reducing quantity of memory. Also, your computer speed is going to be raised to 4x by cutting out several irritating system sounds.
It can fix all kind of errors as well as restore files and folders (registry, windows, system, and applications). Furthermore, using crack kerish doctor 2022 Cleaner you can get free system boost by removing junk files and garbage left behind by various software package developed by a program vendor.
It's time to activate Kerish Doctor in order to remove several record traces, invalid fragments, and corruptions. crack kerish doctor 2022 can enhance the speed of your computer by removing junk files and registry entries accumulated over the years. With the help of Kerish Doctor Desktop Cracked you can cleanup disk files by getting rid of numerous unused files created by different programs and the operating system (several backups).
Every user chooses to use Windows XP or Windows 7 because both of them are stable and cost-effective. Microsoft Windows XP is the better option of Windows 7. crack kerish doctor 2022 can optimize the performance of your XP or Windows 7, without harming them. If you are using Windows XP or 7, this can be a lot better software for you. Don't delete any of the crucial files because this can decrease the performance of your system and cause serious damage to it. This is the reason, why you must download and install Kerish Doctor Crack in order to keep your PC functioning properly.
Download Internet Download Manager Cracked [Updated] [For Mac And Windows]
What is Kerish Doctor good for?
Description: KerishDoctor.exe is a famous application. The type of this program is "freeware", it is available for download free of charge and it is suitable for any Windows operating system, which has been described in the description of the security rating.
There are no known antivirus for KerishDoctor.exe; what is its expert rating?
The security rating of the software is 53% dangerous.
The file has no malicious potential.
The file is very similar to %USERPROFILE%\appdata\local\microsoft\windows\kerishdoctor, which is very similar to %USERPROFILE%\appdata\local\microsoft\windows\kerishdoctor\system. The file size is 2,934,448 bytes (8% of all occurrences) or 4,490,872 bytes.
KerishDoctor.exe is able to record keyboard and mouse inputs, manipulate other programs and monitor applications.
Therefore the technical security rating is 31% dangerous.
If KerishDoctor.exe is located in a subfolder of the user's profile folder, the security rating is 44% dangerous. The file size is 2,934,448 bytes (33% of all occurrences) or 4,490,872 bytes.
KerishDoctor.exe is not a Windows core file. The program has no visible window.
KerishDoctor.exe is able to record keyboard and mouse inputs, manipulate other programs and monitor applications.
Therefore the technical security rating is 31% dangerous.
Download Kaspersky AntiVirus [Crack] [Final Version] For Windows
Kerish Doctor Review
Buy Kerish Doctor v4.7
Click Here
More info…
Click Here
Kerish Doctor Crack is a powerful and very affordable software that allows you to change the appearance of Windows without harmful it. crack kerish doctor 2022 Crack is a portable and reliable computer application that is from PC cleaner. This application can also secure your computer system from harmful things. It can also helps the computer system defrag your hard drive to make it all packed with data. You can easily get the pc from its defrag option.
Another useful function in the Kerish Doctor program is that it is able to hide all shortcuts on the start menu. You can decide which types of shortcuts you want to appear on the start menu: programs, system files, handy folders, and more. If a shortcut needs to be added, simply access the start menu editor (start "cmd", then type "msexplorer", and then the start menu path) and drag the shortcut to the "Shortcut Hidden" section in the menu. You can also change the names of shortcuts and folder paths, and move and duplicate them. The utility can also remove unwanted shortcuts, which allows you to reclaim the space. A cleanup module can also be used to clear out your temp files and temporary files.
Kerish Doctor can scan and fix the registry and other problems with your PC. The utility scans the registry and identifies issues that may cause problems. It can check for outdated or broken file and program settings in the registry, as well as the root causes of these problems. For example, it will be able to discover that an undesired program has been defined as a "super-user". The utility can also be used to remove unwanted shortcuts.
Download Kaspersky Total Security Cracked [Latest Version] [FRESH]
Main benefits of Kerish Doctor
Latest release of Glary Malware Hunter Pro has the feature which helps you easily remove malicious programs from your computer. The main aim of this tool is to secure your online as well as offline activities. Apart from offline activities, this tool can also remove the malware that has been placed in your computer.
Click on the download button from the download link below to start the download process. A simple instructions will guide you step by step on how to install crack kerish doctor 2022 on your PC:
The windows version of Kerish Doctor is compatible with Windows XP, Windows 7, Windows Vista, Windows Server 2003, Windows Server 2008, Windows Server 2008 R2, Windows 8, and Windows 8.1. The application is compatible with 32-bit and 64-bit systems.
Flexible appointments. In the past, patients who needed a specialist usually had to make a doctor's appointment months in advance. We strive to make it as easy as possible for patients to access care from a large number of specialists.
Great jobs. We have great jobs. We are proud to be the largest private provider of obstetric care in New York State with more than 60 doctors. But the best part is that our team is very rewarding and we offer a range of benefits to support our employees.
The file c:\program files\program name\uninstall.ini contains the current settings that define this software. You may use the two methods to set the location of the uninstall.ini file:
- A new location, via Registry settings The default location, which is currently set to "C:\Program Files\UninstallErrors".
Kerish Doctor installs program files for Windows and some files for your profile. In addition, there are files in your profile that are not crack kerish doctor 2022 files. Without the uninstall.ini file's settings, your computer may be unstable and function incorrectly.


text:
The world of Princesses Love Autumn is an exciting one indeed, and luckily you are on the right site to find similar games on a daily basis. Visit Supergames.com and have your fill of fun! Play Princesses Love Autumn, one of our best fashion games!
These princesses are in love with the colors of the Autumn. Wearing them is absolutely breathtaking. They can't wait to create some special fall outfits and go out for a walk in the park. Today they are planning to do a fashion challenge and see which of them will create the most beautiful Autumn outfit. Help them mix and match different pants, skirts, dresses, tops and coats and make sure to choose some pretty Autumn colors.
Did you like Princesses Love Autumn? Find similar games from the following list:
Try some of our other free games from our fashion category for another fresh and unforgettable experience!


text: Why Dynamic Posturology Is Beneficial For All Ages Video Summary: Dynamic posturology works for all ages. The number one priortity in dynamic posturology is movement and strength. The approach to training different age groups may vary but the principles stay the same. By awpts|2015-03-18T16:30:00+00:00March 18th, 2015|Video| Share This Post With Others! FacebookTwitterLinkedInWhatsAppPinterestEmail Related Posts Training Well For Flights February 26th, 2019 | 0 Comments Fat Loss VS Weight Loss February 26th, 2019 | 0 Comments 5 Best Exercises for Lean Muscle (Women Edition) February 26th, 2019 | 0 Comments How to Build Muscle Safely February 25th, 2019 | 0 Comments


text:
Stewart platform
I presume Im preaching to the converted here but was astonished at what started out as an undergrad project mushroomed into and astonish flight simulator chair
and watch the vids and be gobsmacked, i was
how many Unos does it take ?
Always look on the bright side of life
how many Unos does it take ?
Not many.
If you'd like to build something like this check out Paul McWhorter's 9-axis IMU series
In 26 video lectures he'll teach you everything you ever wanted to know about PID
Here's the introduction video: Lesson one
By the time you get to lesson 22 he'll have you building this:
Note that's he's only using one Arduino throughout this entire course.
If you are interested in learning PID I strongly recommend Paul's course on the 9-axis IMU.
26 videos, about 26 hours. Can't beat that. 👍
DroneBot Workshop Robotics Engineer
Many thanx for the tip. I majored in control theory eons ago and could sure do with a refresher. We didnt have such things as self tuning PID algorithms (a control box<£12)
FWIW I am totally blown away by Boston dynamics and what they achieve with their robots. I could never have dreamt of such performance
Then again it amazes me what advanced topics some builders are attempting with the humble Uno. Arduino have laid open a whole world of affordable projects that could never have been conceived 10 years ago.
Where will it go?
I can foresee in the next few years
Automated warehouse picking Ocado
Automated container terminal
AI Interviewer
These have a bad press at the moment because they are underdeveloped. It wont be long before large labour employers eg Amazon will carry out basic interviews using such AI machines
Not much focus is directed towards the frailties of human interviewers and how stressful it is dealing with Joe Public all day long
Automatic Traffic Control
It is long overdue now that speed control of vehicles travelling on motorways on the grounds of greatly enhanced safety and maximising of road capacity
I could see whole streams of VIP coaches barreling along the fast lane of say the M1. Each coach fitted with radar range finder for the coach in front and so on. The whole traffic stream monitored via wifi (5G)
All vehicles fitted with transponders and given instruction how to proceed - a hybrid version of self driving
and so on, just a few came to my mind
It just shows that control systems were once a nerdy backwater of Engineering but now it offers a very fruitful career for young graduates and technicians
How many future areas can you think of ;-}
Always look on the bright side of life